THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
157,165,492
Share change
-5,253,291
Total reported value
$980,713,228
Put/Call ratio
57%
Price per share
$6.24
Number of holders
141
Value change
-$29,803,080
Number of buys
71
Number of sells
62

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2018

As of 30 Jun 2018, THERAPEUTICSMD INC - COM (TXMD) was held by 141 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 157,165,492 shares. The largest 10 holders included Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, FMR LLC, STATE STREET CORP, Voya Investment Management LLC, and First Eagle Investment Management, LLC. This page lists 141 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.